Top Non-Small Cell Lung Cancer (NSCLC) Companies, Leaders & Major Players

This list of the top companies of Non-Small Cell Lung Cancer (NSCLC) is drawn from assessments by Mordor Intelligence analysts and expert advisors via their extensive research to identify the brands, leaders and major players active in Non-Small Cell Lung Cancer (NSCLC) sector.

Top Non-Small Cell Lung Cancer (NSCLC) Companies

  1. Roche

  2. Bristol-Myers Squibb

  3. Pfizer

  4. AstraZeneca

  5. Novartis

*Disclaimer: Top companies sorted in no particular order

Non-Small Cell Lung Cancer (NSCLC) Market Major Players

Non-Small Cell Lung Cancer (NSCLC) - Competitive Concentration

Non-Small Cell Lung Cancer (NSCLC) Market Concentration

List of Non-Small Cell Lung Cancer (NSCLC) Companies

  • AstraZeneca

  • Merck

  • Roche

  • Bristol-Myers Squibb

  • Novartis

  • Pfizer

  • Eli Lilly and Company

  • Amgen

  • BeiGene

  • Takeda Pharmaceuticals

  • Regeneron

  • Sanofi

  • Daiichi Sankyo

  • Johnson & Johnson

  • Boehringer Ingelheim

  • Innovent Biologics

  • Exelixis

  • Mirati Therapeutics

  • Blueprint Medicines

  • Zai Lab

Get more insights on Non-Small Cell Lung Cancer (NSCLC) industry from our comprehensive report

Complete your form and get your market insights delivered to your inbox

Takes less than 10 seconds